drugset / Trial / NCT00713154

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

NCT00713154 ↗

Phase 2 Terminated 16 enrolled Mitos Pharmaceuticals
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine if MTS-01 is effective in preventing radiotherapy-induced hair loss in patients receiving whole brain radiotherapy

Timeline

Start
2007-04
Primary completion
2007-09
Completion
2008-09

Outcome

Outcome not reported

Stopped: “Major planned study protocol modifications”

Drugs

EvaluationDrugModalityDoseRoute
Comparator MTS-01 Unknown 7 % Topical

Indications